P

Inventor

WU SHENG-JIUN

US36 patents
⚠️ This page may combine multiple inventors who share the name “WU SHENG-JIUN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

JANSSEN BIOTECH INC

21 patents
US9522957B2Dec 20, 2016

Method of treating an inflammatory condition by administering toll-like 3 receptor antagonists

JANSSEN BIOTECH INC10 citations92
US9212227B2Dec 15, 2015

ST2L antibody antagonists for the treatment of ST2L-mediated inflammatory pulmonary conditions

JANSSEN BIOTECH INC13 citations91
US9090694B2Jul 28, 2015

ST2L antibody antagonists

JANSSEN BIOTECH INC19 citations91
US9481731B2Nov 1, 2016

Toll-like receptor 3 antagonists

JANSSEN BIOTECH INC9 citations83
US8999333B2Apr 7, 2015

Human tissue factor antibody and uses thereof

JANSSEN BIOTECH INC9 citations83
US8951525B2Feb 10, 2015

Human tissue factor antibody and uses thereof

JANSSEN BIOTECH INC11 citations83
US9951137B2Apr 24, 2018

ST2L antagonists and methods of use

JANSSEN BIOTECH INC4 citations82
US9371376B2Jun 21, 2016

Anti-PHF-tau antibodies and their uses

JANSSEN BIOTECH INC10 citations80
US10894830B2Jan 19, 2021

Antibodies specifically binding PD-1, TIM-3 or PD-1 and TIM-3 and their uses

JANSSEN BIOTECH INC7 citations78
US10450377B2Oct 22, 2019

ST2L antagonists and methods of use

JANSSEN BIOTECH INC1 citations71
US10196440B2Feb 5, 2019

Anti-PHG-tau antibodies and their uses

JANSSEN BIOTECH INC3 citations71
US10000559B2Jun 19, 2018

Anti-PHF-tau antibodies and their uses

JANSSEN BIOTECH INC2 citations71
US10844122B2Nov 24, 2020

Prostate specific membrane antigen (PSMA) bispecific binding agents and uses thereof

JANSSEN BIOTECH INC4 citations68
US12065488B2Aug 20, 2024

Anti-IL-6 antibody

JANSSEN BIOTECH INC0 citations62
US11180549B2Nov 23, 2021

Methods of suppressing rheumatoid arthritis using an anti-IL-6 antibody

JANSSEN BIOTECH INC0 citations62
US9932404B2Apr 3, 2018

Methods of reducing clinical symptoms of viral infection by administering a toll-like receptor 3 antagonist

JANSSEN BIOTECH INC1 citations62
US9745371B2Aug 29, 2017

Anti-PHF-tau antibodies and their uses

JANSSEN BIOTECH INC1 citations60
US11866499B2Jan 9, 2024

Monospecific and multispecific anti-TMEFF2 antibodies and their uses

JANSSEN BIOTECH INC0 citations57
US12173064B2Dec 24, 2024

Antibodies specifically binding PD-1, TIM-3 or PD-1 and TIM-3 and their uses

JANSSEN BIOTECH INC0 citations56
US9631016B2Apr 25, 2017

Pen-injector device containing anti-IL-6 antibodies

JANSSEN BIOTECH INC0 citations51
US9340613B2May 17, 2016

Anti-IL-6 antibodies, compositions, methods and uses

JANSSEN BIOTECH INC0 citations51

CUNNINGHAM MARK

5 patents

CHEN YAN

4 patents

ALMAGRO JUAN CARLOS

2 patents

APPLIED MOLECULAR EVOLUTION

1 patent

CHAN YAN

1 patent

JANSSEN PHARMACEUTICA NV

1 patent

UNIV NEW YORK

1 patent